Resource Library
Search >>
Welcome to the Eurofins US Food, Feed, and Supplement testing laboratories resource library.
Here you will find blogs, webinars, scientific articles, videos, case studies, white papers, and more about the services we offer for your industry.
Use the box below to search, or click on the service or industry link that you would like to review resources for and you will be taken to all of the resources we have on that topic. Please reach out to us if you are looking for information and do not see it here!
Search >>
Service:
Allergens
Authenticity
Contaminants
Dairy
Environmental Monitoring (EMP)
Food Microbiology Process Validation
GMO Testing
To view by media type, use the buttons below.
Eurofins News:
This webinar outlines the concept, design and execution of appropriate validation strategies and procedures intended to mitigate microbiological hazards in Low-Water Activity Foods. In the context of FDA regulations, low-water activity foods (LWAF) are those products with a water activity (aw) of less than 0.85. For many decades, these products were believed to present a low microbiological hazard risk. Various food related illness outbreaks, starting with a massive outbreak of salmonellosis due to peanut butter consumption in 2008-2009, raised awareness of the risk resulting from extended survival of pathogens in these products even in the absence of active growth. Original airdate August 23, 2022.
High-Pressure Processing is a food processing technology that enables food safety while maintaining food quality. Learn how this high-pressure technology contributes to food science and testing to help support HPP processing and HPP food safety.
Validation of aseptic fillers intended for the production of low-acid, shelf-stable products is a core requirement of the FDA’s low-acid canned food (LACF) regulations (21CFR113 and 108.35). Microbiological challenges of the aseptic zone and packaging material sterilization cycles are important components of the validation process. These challenges are often conducted at the production site using non-pathogenic surrogate organisms that mimic the resistance of the pertinent target pathogen. This presentation will provide a brief history of the use of such surrogates for the validation of low-acid aseptic fillers along with the approach we have used to qualify the surrogates as adequate for the intended technology.”